Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan Todd

Showing results (11-20 of 62) with videos related to

Pageof 7
Sort By:
Statistics in Medicine|February 16, 2013
Conditionally unbiased estimation in phase II/III clinical trials with early stopping for futilityPeter K Kimani, Susan Todd, Nigel Stallard
Statistics in Medicine|April 24, 2015
Estimation after subpopulation selection in adaptive seamless trialsPeter K Kimani, Susan Todd, Nigel Stallard
Statistics in Medicine|July 14, 2007
Active-control trials with binary data: a comparison of methods for testing superiority or non-inferiority using the odds ratioArminda Lucia Siqueira, Anne Whitehead, Susan Todd
Pharmaceutical Statistics|February 17, 2012
A practical comparison of blinded methods for sample size reviews in survival data clinical trialsSusan Todd, Elsa Valdés-Márquez, Jodie West
Statistical Methods in Medical Research|February 5, 2014
Sample size considerations in active-control non-inferiority trials with binary data based on the odds ratioArminda Lucia Siqueira, Susan Todd, Anne Whitehead
Journal of Biopharmaceutical Statistics|July 19, 2005
An adaptive group sequential design for phase II/III clinical trials that select a single treatment from severalPatrick J Kelly, Nigel Stallard, Susan Todd
Trials|June 27, 2021
Recommendations for designing and analysing multi-arm non-inferiority trials: a review of methodology and current practiceJake Emmerson, Susan Todd, Julia M Brown
Biometrical Journal. Biometrische Zeitschrift|November 1, 2013
A comparison of methods for constructing confidence intervals after phase II/III clinical trialsPeter K Kimani, Susan Todd, Nigel Stallard
Medical Decision Making : an International Journal of the Society for Medical Decision Making|December 3, 2021
Expected Value of Sample Information to Guide the Design of Group Sequential Clinical TrialsLaura Flight, Steven Julious, Alan Brennan, et al.
BMC Medical Research Methodology|January 9, 2020
Comparison of Bayesian and frequentist group-sequential clinical trial designsNigel Stallard, Susan Todd, Elizabeth G Ryan, et al.
Pageof 7

Showing results (11-20 of 62) with videos related to

Sort By:
Pageof 7
Statistics in Medicine|February 16, 2013
Conditionally unbiased estimation in phase II/III clinical trials with early stopping for futilityPeter K Kimani, Susan Todd, Nigel Stallard
Statistics in Medicine|April 24, 2015
Estimation after subpopulation selection in adaptive seamless trialsPeter K Kimani, Susan Todd, Nigel Stallard
Statistics in Medicine|July 14, 2007
Active-control trials with binary data: a comparison of methods for testing superiority or non-inferiority using the odds ratioArminda Lucia Siqueira, Anne Whitehead, Susan Todd
Pharmaceutical Statistics|February 17, 2012
A practical comparison of blinded methods for sample size reviews in survival data clinical trialsSusan Todd, Elsa Valdés-Márquez, Jodie West
Statistical Methods in Medical Research|February 5, 2014
Sample size considerations in active-control non-inferiority trials with binary data based on the odds ratioArminda Lucia Siqueira, Susan Todd, Anne Whitehead
Journal of Biopharmaceutical Statistics|July 19, 2005
An adaptive group sequential design for phase II/III clinical trials that select a single treatment from severalPatrick J Kelly, Nigel Stallard, Susan Todd
Trials|June 27, 2021
Recommendations for designing and analysing multi-arm non-inferiority trials: a review of methodology and current practiceJake Emmerson, Susan Todd, Julia M Brown
Biometrical Journal. Biometrische Zeitschrift|November 1, 2013
A comparison of methods for constructing confidence intervals after phase II/III clinical trialsPeter K Kimani, Susan Todd, Nigel Stallard
Medical Decision Making : an International Journal of the Society for Medical Decision Making|December 3, 2021
Expected Value of Sample Information to Guide the Design of Group Sequential Clinical TrialsLaura Flight, Steven Julious, Alan Brennan, et al.
BMC Medical Research Methodology|January 9, 2020
Comparison of Bayesian and frequentist group-sequential clinical trial designsNigel Stallard, Susan Todd, Elizabeth G Ryan, et al.
Pageof 7